Feedback / Questions
Rybrevant (amivantamab-vmjw) - J&J
Leclaza (lazertinib) - J&J
https://www.cancernetwork.com/view/mariposa-first-line-amivantamab-plus-lazertinib-in-egfr-mutated-nsclc
Joshua K Sabari; Helena A Yu; Nathan A Pennell; Evan Wu
May 3, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next